Dannielle Appelhans

Dannielle Appelhans

Chief Executive Officer at
Cour Pharmaceuticals Development Co., Inc.
43 year
Health Technology
Consumer Services
Commercial Services

Profile

Dannielle Appelhans is currently President, Chief Executive Officer & Director at Cour Pharmaceuticals Development Co., Inc. since 2024.
Former roles include President & Chief Executive Officer at Rubius Therapeutics, Inc. from 2022 to 2023, Independent Director at Generation Bio Co. from 2022 to 2026, Senior Manager-Engagement at McKinsey & Co., Inc. from 2011 to 2014, and Chief Technical Officer at Novartis Gene Therapies, Inc. from 2020 to 2021.
Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at the University of Michigan, and an MBA from MIT Sloan School of Management.

Dannielle Appelhans active positions

CompaniesPositionStart
Chief Executive Officer 01/09/2024

Former positions of Dannielle Appelhans

CompaniesPositionEnd
GENERATION BIO CO. Director/Board Member 06/02/2026
RUBIUS THERAPEUTICS Chief Executive Officer 03/03/2023
AVEXIS INC Chief Tech/Sci/R&D Officer 01/01/2021
Corporate Officer/Principal 01/12/2014
See the detail of Dannielle Appelhans's experience

Training of Dannielle Appelhans

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Dannielle Appelhans
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!